Trailing-twelve-month (TTM) revenue is $494.73 Million with a year-over-year growth of +2.30%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2026Period ended 2025-10-31 | $124,545,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-26 |
| Q4 FY2026Period ended 2026-01-31 | $124,785,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-12 |
| Q1 FY2027Period ended 2026-04-30 | $120,967,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-28 |
| Q2 FY2027Period ended 2026-07-31 | $124,436,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-27 |
| TTM revenue | $494,733,000 |
Current P/S: $1,352,677,208 market capitalization ÷ $494,733,000 TTM revenue = 2.73x.
Market capitalization source: FMP quote. Quote observed 2026-09-23T20:00:03.000Z. Latest revenue period ended 2026-07-31.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2027 (2026-07-31): $124.44M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-24T00:16:13.175Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-01-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-01-31 · USD | FY20222022-01-31 · USD | FY20232023-01-31 · USD | FY20242024-01-31 · USD | FY20252025-01-31 · USD | FY20262026-01-31 · USD |
|---|---|---|---|---|---|---|
| Non-US | $50M | $69M | $88M | $119M | $130M | $142M |
| UNITED STATES | $163M | $213M | $283M | $312M |
$494.73M
$494.73 Million
+2.30%
vs. $483.61M a year ago (TTM)
+15.17%
5 Year compound annual growth rate
1 Year
+2.30%
3 Year
+6.81%
5 Year
+15.17%
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2026 | $492.55M | +$25.05M | +5.36% |
| 2025 | $467.50M | +$36.80M | +8.54% |
| 2024 | $430.70M | +$59.91M | +16.16% |
| 2023 | $370.79M | +$89.40M | +31.77% |
| 2022 | $281.40M | +$67.84M | +31.77% |
| 2021 |
TTM Growth
+2.30%
3-Year CAGR
+6.81%
5-Year CAGR
+15.17%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 31 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-24T00:16:13.175Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
| $351M |
| $213.56M |
| +$47.20M |
| +28.38% |
| 2020 | $166.35M | +$48.53M | +41.19% |
| 2019 | $117.82M | +$38.19M | +47.96% |
